Rapid Influenza Diagnostic Tests (RIDT) Market Size, Share, Trends, Growth and Forecast 2025

Rapid Influenza Diagnostic Tests (RIDT) Market

Rapid Influenza Diagnostic Tests (RIDT) Market by Patient (Adult and Pediatric); by Product (Influenza B RIDT and Influenza A RIDT); by End User (Research Laboratories, Diagnostics Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5012 Published Date: Nov-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 448.4 Million USD 684.5 Million 6.4% 2018

Rapid Influenza Diagnostic Tests (RIDT) Market

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size : Overview

Global demand for rapid influenza diagnostic tests (RIDT) market was valued at approximately USD 448.4 million in 2018, and is expected to generate revenue of around USD 684.5 million by end of 2025, growing at a CAGR of around 6.4% between 2019 and 2025. 

The report covers forecast and analysis for the rapid influenza diagnostic tests (RIDT) market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the rapid influenza diagnostic tests market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rapid influenza diagnostic tests market on a global as well as regional level.

Global Rapid Influenza Diagnostic Tests (RIDT) Market SizeRequest Free Sample

In order to give the users of this report a comprehensive view on the rapid influenza diagnostic tests market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the rapid influenza diagnostic tests market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the rapid influenza diagnostic tests market on global and regional basis.

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size : Segmentation

The study provides a crucial view on the rapid influenza diagnostic tests by segmenting the market based on product, patient, end user and region. All the segments of rapid influenza diagnostic tests market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Influenza is one of the major disease burdens worldwide and early detection is important for emerging pandemic strains. Influenza virus can be detected using virus isolation in cell culture, direct antigen detection or RT-PCR (reverse transcriptase-polymerase chain reaction) based detection of influenza specific RNA. Wide range of rapid detection test kits are available commercially. Rapid influenza diagnostic test (RIDT) detects presence of influenza viral nucleoprotein antigen for diagnosis of current influenza infection. Commercially used RIDTs can detect the infection within 30 minutes. These tests mostly use immunoassays to detect viral antigen. However some tests detect neuraminidase activity. Rapid detection tests help reduce blood tests and chest radiography in clinical settings.

The demand for rapid influenza diagnostic tests market is driven by growing demand for quick and cheaper diagnostic tests, increasing government initiatives to control influenza outbreaks, increasing geriatric population and technological advancements in immunoassay techniques and manufacturing of diagnostic kits. Additionally, increasing awareness, easy availability of test kits and increasing healthcare expenditure in developing countries are expected to propel the market growth. However, lack of skilled professionals may restrain the market growth.

Based on product, global rapid influenza diagnostic tests market is bifurcated into influenza B RIDT and influenza A RIDT. Influenza A RIDT accounted for largest market share in 2018 and is projected to hold its dominance over the forecast period. Growing number of population suffering from influenza worldwide will positively impact the RIDT for influenza A product market growth.

Based on patient market is segmented into adult and pediatric. Adult patient population segment accounted for the largest market share in 2018 and pediatric patient type segment is projected to grow rapidly over the forecast period. Increasing risk of influenza in pediatric patients will boost the market growth for pediatric segment.

The end user segment is divided into research laboratories, diagnostics centers, hospitals and other end users. Hospitals were the largest end users for rapid influenza diagnostic tests market in 2018. Large patient pool, presence of developed infrastructure in hospitals attribute to the largest market share.

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size : Regional Analysis

North America held largest market share of the global rapid influenza diagnostic tests market in 2018. Government initiatives to control influenza outbreaks, growing awareness, increasing healthcare spending and availability of technological advanced products are factors driving the market in this region. Europe was second dominating market. Asia Pacific region is estimated to be highly growing market for rapid influenza diagnostic tests. Growing awareness, increasing health care spending, increasing geriatric population base are factors driving the market growth. Latin America is expected to register moderate growth over the forecast period. Middle East and Africa will register slower growth compared to other regions due to poor infrastructure and poverty.

Rapid Influenza Diagnostic Tests (RIDT) Market Size: Report Scope

Report Attributes Report Details
Report Name Rapid Influenza Diagnostic Tests (RIDT) Market Size Report
Market Size in 2018 USD 448.4 Million
Market Forecast in 2025 USD 684.5 Million
Growth Rate CAGR of 6.4%
Number of Pages 188
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Becton, Dickinson and Company, DiaSorin S.p.A, SA Scientific, Meridian Bioscience Inc., CorisBioconcep, Analytik Jena, Abbott, Quidel Corporation, Roche, Princeton BioMeditech Corporation among others.
Segments Covered By Patient, By Product , By End-Use And By Region.
Base Year 2018
Historical Year 2015 to 2018
Forecast Year 2018 - 2025
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Rapid Influenza Diagnostic Tests (RIDT) Market Size: Competitive Players

  • Becton
  • Dickinson and Company
  • DiaSorin S.p.A
  • SA Scientific
  • Meridian Bioscience Inc.
  • CorisBioconcep
  • Analytik Jena
  • Abbott
  • Quidel Corporation
  • Roche
  • Princeton BioMeditech Corporation among others.

The report segment of global rapid influenza diagnostic tests market as follows:

Global Rapid Influenza Diagnostic Tests Market: Product

  • Rapid Influenza Diagnostic Test for Influenza A
  • Rapid Influenza Diagnostic Test for Influenza B

Global Rapid Influenza Diagnostic Tests Market: By Patient

  • Pediatric
  • Adult

Global Rapid Influenza Diagnostic Tests Market: By End User

  • Hospitals
  • Diagnostics Centers
  • Research Laboratories
  • Other End Users

Global Rapid Influenza Diagnostic Tests Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Global demand for rapid influenza diagnostic tests (RIDT) market was valued at approximately USD 448.4 million in 2018, and is expected to generate revenue of around USD 684.5 million by end of 2025

Becton, Dickinson and Company, DiaSorin S.p.A, SA Scientific, Meridian Bioscience Inc., CorisBioconcep, Analytik Jena, Abbott, Quidel Corporation, Roche, Princeton BioMeditech Corporation among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed